Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy against Castration-Resistant Prostate Cancer

Daniel Gioeli(George Mason University), Michael J. Weber(University of Virginia Health System)
Molecular Cancer Therapeutics
June 28, 2011
Cited by 66


Related Papers